Search results
Results From The WOW.Com Content Network
Timeline CDC poster recommending the use of non-medical face masks to slow transmission of COVID-19. 2020 Early recommendations. Initially, the U.S. government did not recommend the use of face masks by the general public outside of medical settings to protect themselves from COVID-19, as to prevent shortages of medical-grade personal protective equipment (PPE) for doctors treating COVID-19 ...
The COVID-19 vaccination campaign in the United States is an ongoing mass immunization campaign for the COVID-19 pandemic in the United States. The Food and Drug Administration (FDA) first granted emergency use authorization to the Pfizer–BioNTech vaccine on December 10, 2020, [7] and mass vaccinations began four days later.
This brought the total confirmed U.S. deaths due to coronavirus to 22: 19 in Washington, 1 in California, and 2 in Florida. Hawaii: Second case is reported by Governor David Ige and State health officials is an elderly man who tested positive after returning from travel to Washington state earlier in the month.
e. SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), the virus that causes COVID-19, was isolated in late 2019. [1] Its genetic sequence was published on 11 January 2020, triggering an urgent international response to prepare for an outbreak and hasten the development of a preventive COVID-19 vaccine.
During the COVID-19 pandemic, face masks or coverings, including N95, FFP2, surgical, and cloth masks, have been employed as public and personal health control measures against the spread of SARS-CoV-2, the virus that causes COVID-19 . In community and healthcare settings, the use of face masks is intended as source control to limit ...
A respiratory syncytial virus (RSV) shot, which will be Moderna’s second drug in the market following its COVID shot that debuted during the pandemic, is poised for a U.S. approval decision by ...
The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National Institute of Allergy and Infectious Diseases (NIAID), and the Biomedical Advanced Research and Development Authority (BARDA). Depending on the jurisdiction, it is authorized for use in ...
On 4 February 2020, US Secretary of Health and Human Services Alex Azar published a notice of declaration under the Public Readiness and Emergency Preparedness Act for medical countermeasures against COVID‑19, covering "any vaccine, used to treat, diagnose, cure, prevent, or mitigate COVID‑19, or the transmission of SARS-CoV-2 or a virus ...